A study to assess the effectiveness of Homoeopathic individualized medicine in Primary or Idiopathic Hyperhidrosis (Excessive sweating)

Effectiveness of Homoeopathic individualized medicine in Primary or Idiopathic Hyperhidrosis: A randomized placebo controlled cross-over clinical trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/086990

Enrollment

Registered

2025-05-15

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R61- Generalized hyperhidrosis

Interventions

Intervention1: Homoeopathic individualized medicine: Homoeopathic individualized medicine will be administered in suitable potency and dose according to the Homoeopathic principles to Group A and Gro

Eligibility

Inclusion criteria

Inclusion criteria: 1. Cases satisfying the operational definition Operational Definition: A. Cases with excessive sweating of 6 months or more in duration, with 4 or more of the following: Primarily involving eccrine-dense(axillae or palms or soles or craniofacial) sites,Bilateral and symmetric,Absent nocturnally,Episodes at least weekly,Onset at age 25 years or younger,Positive family history,Impairment of daily activities. B. Cases satisfying a Score of 2 or above in the Hyperhidrosis Disease Severity Scale(HDSS) 2. Age group of 10-40 years

Exclusion criteria

Exclusion criteria: 1. Patients diagnosed with Diabetes, abnormal Thyroid function tests 2. Medications like antidepressants, antibiotics, antivirals, antipyretics, NSAIDs 3. Pregnant and Menopausal women 4. Patients with History of Cancer, Stroke

Design outcomes

Primary

Measure	Time frame
1. The effectiveness of Homoeopathic individualized medicine in reducing sweating severity determined using the Hyperhidrosis Disease severity Scale(HDSS). 2. The effectiveness of Homoeopathic individualized medicine in reducing sweating severity determined using gravimetry. 3. The improvement in quality of life determined using the Hyperhidrosis Quality of Life Index(HidroQoL).Timepoint: The outcomes will be measured and recorded at the Baseline,at 6 weeks,at 8 weeks and at 14 weeks.	—

Measure

Time frame

1. The effectiveness of Homoeopathic individualized medicine in reducing sweating severity determined using the Hyperhidrosis Disease severity Scale(HDSS). 2. The effectiveness of Homoeopathic individualized medicine in reducing sweating severity determined using gravimetry. 3. The improvement in quality of life determined using the Hyperhidrosis Quality of Life Index(HidroQoL).Timepoint: The outcomes will be measured and recorded at the Baseline,at 6 weeks,at 8 weeks and at 14 weeks.

—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Thara K

Government Homoeopathic Medical College Kozhikode

drthararaj@gmail.com9745245755

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026